Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
40.8M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
7.92M
-
Shares change
-
+7.92M
-
Total reported value, excl. options
-
$100M
-
Value change
-
+$100M
-
Number of buys
-
39
-
Price
-
$12.67
Significant Holders of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) as of Q3 2021
39 filings reported holding RXST - RxSight, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.92M shares
of 40.8M outstanding shares and own 19.42% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.05M shares), ORBIMED ADVISORS LLC (1.25M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (900K shares), FEDERATED HERMES, INC. (510K shares), VANGUARD GROUP INC (408K shares), BlackRock Inc. (350K shares), MILLENNIUM MANAGEMENT LLC (330K shares), Magnetar Financial LLC (281K shares), RTW INVESTMENTS, LP (150K shares), and CAAS CAPITAL MANAGEMENT LP (100K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.